Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2154

Journal of Biotechnology & Biomaterials received 2154 citations as per Google Scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Recommended Journals
Share This Page

Extended spectrum beta-lactamase in clinical isolates of Escherichia coli and Klebsiella pneumoniae from the Tamale teaching hospital

3rd Annual Conference and Expo on Biomaterials

F K M Tetteh, J A Opintan, A Ablordey and N Obeng Nkrumah

University of Ghana, Ghana Noguchi Memorial Institute for Medical Research, Ghana

Posters & Accepted Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X-C1-089

Abstract
Extended spectrum beta-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae are pathogens of significant public health interest to which new antibiotics therapies are urgently needed. This study was designed to determine the prevalence of ESBLs in clinical isolates of E. coli and K. pneumoniae from patients attending the Tamale teaching hospital (TTH). A total of 140 isolates of E. coli (83.6%; n=117) and K. pneumoniae (16.4%; n=23) were cultured from clinical specimens of consenting patients. Antimicrobial susceptibility was determined using the Kirby-Bauer disc diffusion method. Screening and confirmation for ESBL-producing phenotypes among the clinical isolates were performed according to the guidelines of the Clinical and Laboratory Standard Institute, 2012. Escherichia coli and K. pneumoniae positive for ESBL phenotype were examined for the presence of TEM, SHV and CTX-M genes. Sixty two (44.3%) of the 140 isolates expressed ESBLs phenotypically. Of these, 83.9% (n=52) were E. coli and 16.1% (n=10) were K. pneumoniae isolates. The proportion of ESBL-producing isolates were found to be relatively higher in adults (15-65 years) than in neonates (<28 days) [p=0.14]. Majority of the isolates showed high percentage resistance to ampicillin (96%) and tetracycline (89%), but relatively low resistance for amikacin (36%). None of the isolates were resistant to meropenem. The ESBL producers were multidrug resistant compared to non-ESBL-producers (23%, n=14/62 versus 18%, n=14/78; p=0.573). Overall, 74.2% (n=46/62) of the ESBL genotypes expressed BlaCTX-M-1 genes followed by 62.9% (n=39/62) BlaTEM and 16.1% (n=10/62) BlaSHV. Two (3.2%) isolates had both TEM and SHV genes, 29 (46.8%) harbored TEM and CTX-M-1, 2 (3.2%) had SHV and CTXM-1, while 4 (6.5%) harbored all three genes. None expressed genes for CTX-M 2 and CTX-M 9. In univariate comparisons, patients who reported their previous medication as having being prescribed by a Physician and those who reportedly completed their previous medication were more likely to be infected by ESBL organisms. The study showed high ESBL positive E. coli and K. pneumoniae, mostly CTX-M-1 producers in Tamale teaching hospital. Routine laboratory ESBL detection is warranted. tettehmorgan@gmail.com
Biography
Top